| 1 |
Shan L, Shao X, Gu L, Wu M, Lin P, Yu Z, Chen Q, Zhu D. Clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with sarcomatoid dedifferentiation: A PRISMA-compliant systematic review and meta-analysis. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.922150] [Reference Citation Analysis]
|
| 2 |
Wu S, Liang Y, Xu Y, Tong Y, Chen Y, Chen X. Graphene-Based Electrochemical Sensor for Detection of Hepatocellular Carcinoma Markers. Front Chem 2022;10:883627. [DOI: 10.3389/fchem.2022.883627] [Reference Citation Analysis]
|
| 3 |
Zhang HM, Wen DG, Wang Y, Bao YG, Yuan Y, Chen YT, Song B. Arterial Spin Labeling MRI for Predicting Microvascular Invasion of T1 Staging Renal Clear Cell Carcinoma Preoperatively. Front Oncol 2021;11:644975. [PMID: 34084743 DOI: 10.3389/fonc.2021.644975] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Yang J, Wang J, Liang Y, Wang J, Hsu J, Liu G, Li X, Tang Z, Zhang J, Huang Y, Yuan H, Chen Y. ATR and BRCA2 Simultaneous Mutation in a ccRCC With Sarcomatoid Differentiation and Extensive Metastases: A Case Report. Urology 2021;154:45-9. [PMID: 33961890 DOI: 10.1016/j.urology.2021.04.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Zhong W, Zhang F, Huang C, Lin Y, Huang J. Identification of an apoptosis-related prognostic gene signature and molecular subtypes of clear cell renal cell carcinoma (ccRCC). J Cancer 2021;12:3265-76. [PMID: 33976736 DOI: 10.7150/jca.51812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Jiang Y, Gou X, Wei Z, Tan J, Yu H, Zhou X, Li X. Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma. Cancer Cell Int 2020;20:166. [PMID: 32435157 DOI: 10.1186/s12935-020-01242-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
|
